Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 5
Submit an article Journal homepage
189
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival

Thomas C. Shea Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USACorrespondence[email protected]
, MD,
Anne W. Beaven Division of Oncology, Duke University Medical Center, Durham, NC, USA
,
Dominic T. Moore UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA; Department of Biostatistics, UNC, Chapel Hill, NC, USA
,
Jonathan S. Serody Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
,
Don A. Gabriel Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
,
Nelson Chao Division of Cellular Therapy, Duke University Medical Center, Durham, NC, USA
,
Jon P. Gockerman Division of Oncology, Duke University Medical Center, Durham, NC, USA
,
Reynaldo A. Garcia UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
&
David A. Rizzieri Division of Cellular Therapy, Duke University Medical Center, Durham, NC, USA
 show all
Pages 741-748 | Received 10 Oct 2008, Accepted 25 Feb 2009, Published online: 21 Jul 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.